Where Tech Meets Bio

Where Tech Meets Bio

Weekly Highlights

Weekly Tech+Bio Highlights #77: AI-Guided mRNA Vaccine Shrinks Dog's Cancer

Google's AI doctor passes its first clinic test, China's first take-home BCI, OpenFold3 goes fully open, and arXiv is going independent

BiopharmaTrend's avatar
Roman Kasianov's avatar
Andrii Buvailo, PhD's avatar
BiopharmaTrend, Roman Kasianov, and Andrii Buvailo, PhD
Mar 16, 2026
∙ Paid

A lot happened this week, the story getting the most attention: a tech entrepreneur in Australia used ChatGPT and AlphaFold to identify tumor targets in his dog’s cancer after conventional treatment failed, then convinced a university nanomedicine lab to develop a custom mRNA vaccine based on his data. Most tumors have since shrunk dramatically, though …

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 BiopharmaTrend (BPT Analytics Ltd) · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture